Statin toxicity from macrolide antibiotic coprescription

Amit M. Patel, Salimah Shariff, David G. Bailey, David N. Juurlink, Sonja Gandhi, Muhammad Mamdani, Tara Gomes, Jamie Fleet, Y. Joseph Hwang, Amit X. Garg

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Clarithromycin and erythromycin, but not azithromycin, inhibit cytochrome P450 isoenzyme 3A4 (CYP3A4), and inhibition increases blood concentrations of statins that are metabolized by CYP3A4. Objective: To measure the frequency of statin toxicity after coprescription of a statin with clarithromycin or erythromycin. Design: Population-based cohort study. Setting: Ontario, Canada, from 2003 to 2010. Patients: Continuous statin users older than 65 years who were prescribed clarithromycin (n 72591) or erythromycin (n 3267) compared with those prescribed azithromycin (n 68478). Measurements: The primary outcome was hospitalization with rhabdomyolysis within 30 days of the antibiotic prescription. Results: Atorvastatin was the most commonly prescribed statin (73%) followed by simvastatin and lovastatin. Compared with azithromycin, coprescription of a statin with clarithromycin or erythromycin was associated with a higher risk for hospitalization with rhabdomyolysis (absolute risk increase, 0.02% [95% CI, 0.01% to 0.03%]; relative risk [RR], 2.17 [CI, 1.04 to 4.53]) or with acute kidney injury (absolute risk increase, 1.26% [CI, 0.58% to 1.95%]; RR, 1.78 [CI, 1.49 to 2.14]) and for all-cause mortality (absolute risk increase, 0.25% [CI, 0.17% to 0.33%]; RR, 1.56 [CI, 1.36 to 1.80]). Limitations: Only older adults were included in the study. The absolute risk increase for rhabdomyolysis may be underestimated because the codes used to identify it were insensitive. Conclusion: In older adults, coprescription of clarithromycin or erythromycin with a statin that is metabolized by CYP3A4 increases the risk for statin toxicity.

Original languageEnglish (US)
Pages (from-to)869-876
Number of pages8
JournalAnnals of internal medicine
Volume158
Issue number12
DOIs
StatePublished - Jun 18 2013
Externally publishedYes

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Statin toxicity from macrolide antibiotic coprescription'. Together they form a unique fingerprint.

Cite this